Leuprolide Completed Phase 2 Trials for Recurrent Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00454571Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
NCT01750398Bipolar Androgen-based Therapy for Prostate Cancer (BAT)